Literature DB >> 28257597

International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.

S B Coburn1, F Bray2, M E Sherman3, B Trabert1.   

Abstract

Internationally, ovarian cancer is the 7th leading cancer diagnosis and 8th leading cause of cancer mortality among women. Ovarian cancer incidence varies by region, particularly when comparing high vs. low-income countries. Temporal changes in reproductive factors coupled with shifts in diagnostic criteria may have influenced incidence trends of ovarian cancer and relative rates by histologic subtype. Accordingly, we evaluated trends in ovarian cancer incidence overall (1973-1977 to 2003-2007) and by histologic subtype (1988-1992 to 2003-2007) using volumes IV-IX of the Cancer Incidence in Five Continents database (CI5plus) and CI5X (volume X) database. Annual percent changes were calculated for ovarian cancer incidence trends, and rates of histologic subtypes for individual countries were compared to overall international incidence. Ovarian cancer incidence rates were stable across regions, although there were notable increases in Eastern/Southern Europe (e.g., Poland: Annual Percent Change (APC) 1.6%, p = 0.02) and Asia (e.g., Japan: APC 1.7%, p = 0.01) and decreases in Northern Europe (e.g., Denmark: APC -0.7%, p = 0.01) and North America (e.g., US Whites: APC -0.9%, p < 0.01). Relative proportions of histologic subtypes were similar across countries, except for Asian nations, where clear cell and endometrioid carcinomas comprised a higher proportion of the rate and serous carcinomas comprised a lower proportion of the rate than the worldwide distribution. Geographic variation in temporal trends of ovarian cancer incidence and differences in the distribution of histologic subtype may be partially explained by reproductive and genetic factors. Thus, histology-specific ovarian cancer should continue to be monitored to further understand the etiology of this neoplasm.
© 2017 UICC.

Entities:  

Keywords:  histologic subtype; incidence trends; international; ovarian cancer

Mesh:

Year:  2017        PMID: 28257597      PMCID: PMC5595147          DOI: 10.1002/ijc.30676

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  Global epidemiology of hysterectomy: possible impact on gynecological cancer rates.

Authors:  Anne Hammer; Anne F Rositch; Johnny Kahlert; Patti E Gravitt; Jan Blaakaer; Mette Søgaard
Journal:  Am J Obstet Gynecol       Date:  2015-02-25       Impact factor: 8.661

2.  Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.

Authors:  Hannah P Yang; William F Anderson; Philip S Rosenberg; Britton Trabert; Gretchen L Gierach; Nicolas Wentzensen; Kathleen A Cronin; Mark E Sherman
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

3.  Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.

Authors:  Yulan Yan; Renzheng Wu; Shaojing Li; Jinlong He
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2015-03-14       Impact factor: 2.435

4.  Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States.

Authors:  Ray M Merrill
Journal:  Ann Epidemiol       Date:  2006-10-04       Impact factor: 3.797

5.  Graphical presentation of trends in rates.

Authors:  S S Devesa; J Donaldson; T Fears
Journal:  Am J Epidemiol       Date:  1995-02-15       Impact factor: 4.897

Review 6.  Management of germ cell and stromal tumors of the ovary.

Authors:  R E Slayton
Journal:  Semin Oncol       Date:  1984-09       Impact factor: 4.929

Review 7.  Europe the continent with the lowest fertility.

Authors: 
Journal:  Hum Reprod Update       Date:  2010-07-04       Impact factor: 15.610

8.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

Review 9.  Histological classification of ovarian cancer.

Authors:  Tsunehisa Kaku; Shinji Ogawa; Yoshiaki Kawano; Yoshihiro Ohishi; Hiroaki Kobayashi; Toshio Hirakawa; Hitoo Nakano
Journal:  Med Electron Microsc       Date:  2003-03

10.  Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.

Authors:  I dos Santos Silva; A J Swerdlow
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

View more
  92 in total

1.  The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.

Authors:  Citadel J Cabasag; Melina Arnold; John Butler; Manami Inoue; Britton Trabert; Penelope M Webb; Freddie Bray; Isabelle Soerjomataram
Journal:  Int J Cancer       Date:  2019-04-30       Impact factor: 7.396

2.  Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies.

Authors:  Joanne O'Dwyer; Roisin E O'Cearbhaill; Robert Wylie; Saoirse O'Mahony; Michael O'Dwyer; Garry P Duffy; Eimear B Dolan
Journal:  Adv Ther (Weinh)       Date:  2020-08-16

3.  High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy.

Authors:  Alberto Posabella; Philipp Köhn; Alexandros Lalos; Alexander Wilhelm; Robert Mechera; Savas Soysal; Simone Muenst; Uwe Güth; Sylvia Stadlmann; Luigi Terracciano; Raoul A Droeser; Jasmin Zeindler; Gad Singer
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-18       Impact factor: 4.553

4.  Clinical significance of RAD51C and its contribution to ovarian carcinogenesis.

Authors:  Xiao-Li Lu; Si-Sun Liu; Zhen-Fang Xiong; Fen Wang; Xia-Ying Li; Huan Deng
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

Review 5.  Anti-ovarian cancer potential of phytocompound and extract from South African medicinal plants and their role in the development of chemotherapeutic agents.

Authors:  Chella Perumal Palanisamy; Bo Cui; Hongxia Zhang; Mani Panagal; Sivagurunathan Paramasivam; Uma Chinnaiyan; Selvaraj Jeyaraman; Karthigeyan Murugesan; Mauricio Rostagno; Vijayakumar Sekar; Srinivasa Prabhu Natarajan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

6.  Predictors of survival trajectories among women with epithelial ovarian cancer.

Authors:  Lauren C Peres; Sweta Sinha; Mary K Townsend; Brooke L Fridley; Beth Y Karlan; Susan K Lutgendorf; Eileen Shinn; Anil K Sood; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2019-12-12       Impact factor: 5.482

7.  EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).

Authors:  Roberto C Delgado Bolton; Nicolas Aide; Patrick M Colletti; Annamaria Ferrero; Diana Paez; Andrea Skanjeti; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-03       Impact factor: 9.236

8.  Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.

Authors:  Youngjin Han; Boyun Kim; Untack Cho; In Sil Park; Se Ik Kim; Danny N Dhanasekaran; Benjamin K Tsang; Yong Sang Song
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

9.  Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.

Authors:  Shama Virani; Glauco Baiocchi; David Bowtell; Citadel J Cabasag; Kathleen R Cho; Renée T Fortner; Keiichi Fujiwara; Jae-Weon Kim; Martin Köbel; Jean-Emmanuel Kurtz; Douglas A Levine; Usha Menon; Barbara M Norquist; Paul D P Pharoah; Anil K Sood; Shelley T Tworoger; Nicolas Wentzensen; Stephen J Chanock; Paul Brennan; Britton Trabert
Journal:  Carcinogenesis       Date:  2021-06-21       Impact factor: 4.944

10.  International trends in ovarian cancer incidence from 1973 to 2012.

Authors:  Wende Hao; Yue Zhang; Zhefeng Li; Enjie Zhang; Shen Gao; Chenghong Yin; Wentao Yue
Journal:  Arch Gynecol Obstet       Date:  2021-02-22       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.